New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: Design, synthesis and structure-activity relationship

PLoS One. 2017 Sep 18;12(9):e0183807. doi: 10.1371/journal.pone.0183807. eCollection 2017.

Abstract

Sixteen new carboxamide derivatives bearing substituted benzenesulphonamide moiety (7a-p) were synthesized by boric acid mediated amidation of appropriate benzenesulphonamide with 2-amino-4-picoline and tested for anti-inflammatory activity. One compound 7c showed more potent anti-inflammatory activity than celecoxib at 3 h in carrageenan-induced rat paw edema bioassay. Compounds 7g and 7k also showed good anti-inflammatory activity comparable to celecoxib. Compound 7c appeared selectivity index (COX-2/COX-1) better than celecoxib. Compound 7k appeared selectivity index (COX-2/COX-1) a little higher than the half of celecoxib while compound 7g is non-selective for COX-2. The LD50 of compounds 7c, 7g and 7k were comparable to celecoxib.

MeSH terms

  • Animals
  • Cyclooxygenase 1 / chemistry
  • Cyclooxygenase 2 / chemistry*
  • Cyclooxygenase 2 Inhibitors / chemical synthesis*
  • Cyclooxygenase 2 Inhibitors / chemistry*
  • Imidazoles / chemistry*
  • Male
  • Membrane Proteins / chemistry
  • Rats
  • Structure-Activity Relationship
  • Sulfonamides / chemistry*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Imidazoles
  • Membrane Proteins
  • Sulfonamides
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, rat
  • Ptgs2 protein, rat

Grants and funding

The authors received no specific funding for this work.